TRANSFAC-Logo

TRANSFAC FACTOR TABLE, Release 2017.2 - public - 2017-06-30, (C) QIAGEN


AC T23072 XX ID T23072 XX DT 11.01.2006 (created); jma. DT 16.06.2016 (updated); mom. CO Copyright (C), QIAGEN. XX FA PEBP2beta XX SY CBFbeta; PEBP2beta. XX OS Mammalia OC Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; Mammalia XX IN T14315 AML1; Mammalia. IN T02245 AML1b; human, Homo sapiens. IN T09248 AML2-isoform1; human, Homo sapiens. IN T09552 AML3; Mammalia. XX MX M00769 V$AML_Q6. MX M03841 V$PEBP2B_Q6. MX M00984 V$PEBP_Q6. XX DR TRANSPATH: MO000056700. XX RN [1]; RE0035589. RX PUBMED: 14752096. RA Yamaguchi Y., Kurokawa M., Imai Y., Izutsu K., Asai T., Ichikawa M., Yamamoto G., Nitta E., Yamagata T., Sasaki K., Mitani K., Ogawa S., Chiba S., Hirai H. RT AML1 is functionally regulated through p300-mediated acetylation on specific lysine residues. RL J. Biol. Chem. 279:15630-15638 (2004). RN [2]; RE0042557. RX PUBMED: 15138260. RA Jin Y. H., Jeon E. J., Li Q. L., Lee Y. H., Choi J. K., Kim W. J., Lee K. Y., Bae S. C. RT Transforming growth factor-beta stimulates p300-dependent RUNX3 acetylation, which inhibits ubiquitination-mediated degradation RL J. Biol. Chem. 279:29409-17 (2004). XX //